In a groundbreaking achievement that sounds like science fiction, robots have successfully performed two animal surgeries, marking a historic first for autonomous medicine. The surgeries, conducted on a pig and a goat, were completed without direct human control, though doctors remained on standby. The team behind the project hopes this technology will eventually be deployed outside hospital settings, bringing cutting-edge surgical care to remote areas, battlefields, or even your living room. At first glance, this is a miracle of modern engineering. The robots, equipped with advanced AI and precision tools, made clean incisions, manipulated tissues, and closed wounds with a steadiness no human hand can match. The animals recovered without complications, and the researchers are elated. But as the press releases celebrate this 'medical first,' a nagging doubt creeps in: What happens when these surgical robots move beyond supervised trials and into unsupervised practice? Consider the data. What information are these robots collecting during surgery? Every movement, every decision, every patient's internal anatomy is being recorded, stored, and likely analyzed. The same startup behind these robots might also license its data to insurance companies, employers, or even courtrooms. Imagine a future where your health insurance premium is adjusted based on the 'surgical efficiency score' logged by a robot that operated on you. Or where a robot's surgical 'judgment' is used against you in a malpractice dispute, because the AI determined your lifestyle choices made you a 'high-risk' patient. The consequences spiral from there. If a robot can perform surgery on a pig, why not on a human? And if it works in a hospital, why not at home? Tech companies envision a subscription service for 'home surgeries'—a robot arm that arrives via drone, connects to your smart home system, and performs routine procedures while you watch Netflix. But who is liable when the robot misidentifies an appendix? What happens when a software bug causes the robot to stitch the wrong organ? And if your robot surgery is deemed a 'faulty algorithm,' your insurance company might not just raise your premiums—they might deny coverage altogether, arguing you 'chose' a cheaper autonomous option. And let's not forget the data brokers. Your surgical robot will not only know your physical measurements but also your vital signs under stress, your tissue density, and your body's response to anesthesia. That data could be sold to pharmaceutical companies, life insurers, or even advertisers. Imagine getting a targeted ad for a new organ-preserving pill during your post-op recovery. The line between medicine and marketing blurs until it disappears. So yes, robots operating on animals is a historic first. But as we celebrate the precision, we must ask: Who really benefits when the surgeon is nothing more than a sophisticated algorithm?